Skip to content
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2023
  • English
    • Dutch
Menu
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2023
  • English
    • Dutch
Search
Close

31 January 2023 CTR applicable for new trials with medicinal products

On 31 January 2023, the EU Clinical Trial Regulation (CTR) will be applicable for new clinical trials with a medicinal product.

The CTR became applicable as of 31 Januari 2022. A transition period of three years started. During the first year, sponsors can choose to submit a clinical trial application according to the current legislation, or according to the CTR via CTIS. The first transition year ends on 30 January 2023, 00:00 hours.

More information on CTR for investigators can be found on de site of the CCMO: clinical-trials-with-medicinal-products-ctr 

Print or export to pdf
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact

POWERED BY Wild Sea 2020